Sign in

CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company

Enveric Biosciences, Inc.

Sign in to watch
Ticker
ENVB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954484725
Phone
(617) 444-8400
Business address
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
Former names
AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
  1. 4 Open-market buy Director bought 1,023 shares at an average $6.41 ($6,559)
  2. 4 Open-market buy Director bought 124 shares at $6.51 ($807)
  3. 4 Open-market buy Director bought 103 shares at $6.51 ($671)
  4. 4 Open-market buy Director bought 308 shares at $6.51 ($2,005)
  5. 4 Open-market buy Director bought 200 shares at $6.51 ($1,302)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Director bought 1,360 shares at $6.51 ($8,854)
  9. 4 Open-market buy Director bought 28 shares at $6.51 ($182)
  10. 4 Open-market buy Director bought 1,084 shares at $6.51 ($7,057)
  11. 4 Open-market buy Director bought 804 shares at $6.51 ($5,234)
  12. 4 Open-market buy Director bought 100 shares at $6.51 ($651)
  13. 4 Option exercise Director acquired 1,111,111 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy Director bought 146 shares at an average $6.51 ($950)
  17. 4 Open-market buy Director bought 73 shares at $6.51 ($475)
  18. 4 Open-market buy Director bought 112 shares at $6.51 ($729)
  19. 4 Open-market buy Director bought 85 shares at an average $6.48 ($551)
  20. 4 Open-market buy Director bought 127 shares at $6.51 ($827)

Page 9 of 12 · 234 filings